Transforming growth factor-b1 (TGF-β1) potently inhibits human hepatocellular carcinoma (HCC) cell growth. Here we demonstrated that TGF-β1-induced apoptosis is mediated by decreased phosphorylation of cdc2 at Tyr15 accompanied by down-regulation of Wee1 kinase expression. As expected from these results, a Wee1 kinase inhibitor efficiently induced apoptosis in HCC cells in the absence of TGF-β1 treatment. In surgically resected samples, Wee1 kinase was expressed in moderately to poorly differentiated HCC, whereas no Wee1 kinase expression was observed in non-cancerous tissue, including cirrhotic tissue. Our results suggest that Wee1 kinase inhibitors may be a practical novel therapeutic option against advanced HCC. © 2014 Kogiso et al.
CITATION STYLE
Kogiso, T., Nagahara, H., Hashimoto, E., Ariizumi, S., Yamamoto, M., & Shiratori, K. (2014). Efficient induction of apoptosis by Wee1 kinase inhibition in hepatocellular carcinoma cells. PLoS ONE, 9(6). https://doi.org/10.1371/journal.pone.0100495
Mendeley helps you to discover research relevant for your work.